Insider Selling: Paysign (NASDAQ:PAYS) CEO Sells $767,000.00 in Stock

Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer sold 50,000 shares of the firm’s stock in a transaction on Friday, October 9th. The shares were sold at an average price of $15.34, for a total transaction of $767,000.00. Following the transaction, the chief executive officer directly owned 9,113,002 shares of the company’s stock, valued at $139,793,450.68. The trade was a 0.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Newcomer also recently made the following trade(s):

• On Thursday, August 6th, Mark Newcomer sold 150,000 shares of Paysign stock. The stock was sold at an average price of $11.88, for a total transaction of $1,782,000.00.
• On Wednesday, July 29th, Mark Newcomer sold 50,000 shares of Paysign stock. The stock was sold at an average price of $9.38, for a total transaction of $469,000.00.

Paysign Stock Down 5.1%

Shares of Paysign stock opened at $14.80 on Friday. Paysign, Inc. has a twelve month low of $3.08 and a twelve month high of $15.80. The stock has a market cap of $835.61 million, a price-to-earnings ratio of 60.00 and a beta of 0.83. The company’s fifty day moving average is $13.45 and its 200 day moving average is $9.48.

Paysign (NASDAQ:PAYS) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.05. The business had revenue of $28.25 million during the quarter, compared to the consensus estimate of $26.36 million. Paysign had a return on equity of 30.13% and a net margin of 15.67%. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. As a group, equities analysts anticipate that Paysign, Inc. will post 0.58 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on PAYS shares. Barrington Research set a $15.00 price target on Paysign in a research note on Tuesday, August 11th. Wall Street Zen downgraded Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Lake Street Capital lifted their price objective on Paysign from $13.00 to $15.00 and gave the stock a “buy” rating in a research note on Tuesday, September 15th. DA Davidson lifted their price objective on Paysign from $12.00 to $15.00 and gave the stock a “buy” rating in a research note on Wednesday, September 30th. Finally, Weiss Ratings upgraded Paysign from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Three research analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $15.00.

Hedge Funds Weigh In On Paysign

Several institutional investors have recently added to or reduced their stakes in PAYS. BlackRock Inc. bought a new position in shares of Paysign during the 2nd quarter worth approximately $25,219,000. Punch & Associates Investment Management Inc. acquired a new stake in shares of Paysign during the 2nd quarter worth approximately $16,983,000. Renaissance Technologies LLC grew its position in shares of Paysign by 17.4% during the 1st quarter. Renaissance Technologies LLC now owns 1,531,072 shares of the company’s stock worth $9,033,000 after buying an additional 227,300 shares during the period. AWM Investment Company Inc. bought a new stake in shares of Paysign in the 2nd quarter valued at $6,560,000. Finally, Dimensional Fund Advisors LP increased its stake in shares of Paysign by 16.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 575,619 shares of the company’s stock valued at $3,396,000 after acquiring an additional 82,736 shares in the last quarter. 25.89% of the stock is owned by institutional investors and hedge funds.

About Paysign

Paysign, Inc (NASDAQ: PAYS) provides prepaid payment and financial technology solutions, with a focus on healthcare, pharmaceutical and other specialized markets. Its platform supports the issuance and management of prepaid cards, digital payments, account services and related payment-processing activities.

The company’s healthcare offerings include patient assistance and copay programs that help pharmaceutical manufacturers distribute financial support to eligible patients. Paysign also provides payment and card solutions for plasma collection centers, including programs used to compensate plasma donors.